$1000 Invested In Halozyme Therapeutics 15 Years Ago Would Be Worth This Much Today

Article summary

Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 15 years by 8.16% on an annualized basis producing an average annual return of 21.6%. Currently, Halozyme Therapeutics has a market